FDA Inspection 1005657 — Taro Pharmaceutical Industries Ltd.
The FDA completed an inspection of Taro Pharmaceutical Industries Ltd. on February 5, 2017 in Haifa Bay. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 5, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Haifa Bay (Israel)